
Starting at$50/ mowith a 12-week plan
Choose options
Tirzepatide
Active ingredient
glycine
Active ingredient
Follow the dosing directions approved by your clinician.
Weight loss by dose
Estimated share of body weight lost at each weekly dose, beyond diet and exercise alone, from SURMOUNT-1, a 72-week clinical trial of tirzepatide.
micro2.66 mg a week
An estimated 6.3%, less certain
standard6.14 mg a week
An estimated 12.9%
advanced9.3 mg a week, your selected dose
An estimated 15.8%
advanced12.45 mg a week
An estimated 17.1%
Estimated for our doses on a straight line between the 5, 10 and 15 mg weekly groups of SURMOUNT-1, a 72-week trial of tirzepatide in 2,539 adults without diabetes (Jastreboff et al., NEJM 2022), minus the 3.1% the placebo group lost with the same diet and exercise counseling. *No group took less than 5 mg, so the 2.66 mg figure is less certain. The trial used manufacturer-made tirzepatide, not a compounded medication. Compounded medications are not FDA-approved. Individual results vary.
Price comparison
Each provider's starting dose of tirzepatide, per month, including any membership.
Each provider's starting dose, per month, including any required membership, on the plan closest to our 12-week prepay (3-month plans where offered, otherwise month-to-month). Ro and Hims & Hers sell brand-name Zepbound, not compounded tirzepatide. Compounded medications are not FDA-approved.
Starting at$50/ mowith a 12-week plan
Choose optionsStarting at$60.71/ mowith a 12-week plan
Choose options